Effectiveness and safety of transarterial chemoembolization combined with PD-1 inhibitors and lenvatinib for unresectable intrahepatic cholangiocarcinoma

Effectiveness and safety of transarterial chemoembolization combined with PD-1 inhibitors and lenvatinib for unresectable intrahepatic cholangiocarcinoma

Abstract Background The objective of this study was to evaluate the therapeutic effectiveness and safety of transarterial chemoembolization (TACE) combined with programmed cell death-1 (PD-1) inhibitors and lenvatinib in the treatment of unresectable intrahepatic cholangiocarcinoma (uICC). Methods T...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin-Tao Huang, Di Hu, Xin Hong, Wen-Jie Zhou, Jian Shen, Peng-Hua Lv, Xiao-Li Zhu
Formato: Artículo
Lenguaje:English
Publicado: SpringerOpen 2025-02-01
Colección:European Radiology Experimental
Materias:
Camrelizumab
Chemoembolization (therapeutic)
Cholangiocarcinoma
Lenvatinib
Tislelizumab
Acceso en línea:https://doi.org/10.1186/s41747-025-00563-4

Internet

https://doi.org/10.1186/s41747-025-00563-4

Ejemplares similares